Cathelicidin is Critical for Pathogenic T cell Development in Multiple Sclerosis

Gwyer Findlay, Emily (Principal Investigator)

Status	Finished
Effective start/end date	1/01/17 → 6/08/22

Funding

UK-based charities: £693,550.00

3 Article
1 Review article

The Outcome of Neutrophil-T Cell Contact Differs Depending on Activation Status of Both Cell Types
Minns, D., Smith, K. J., Hardisty, G., Rossi, A. G. & Gwyer Findlay, E., 30 Mar 2021, In: Frontiers in Immunology. 12
Research output: Contribution to journal › Article › peer-review

Open Access
File
The neutrophil antimicrobial peptide cathelicidin promotes Th17 differentiation
Minns, D., Smith, K. J., Alessandrini, V., Hardisty, G., Melrose, L., Jackson-Jones, L., MacDonald, A. S., Davidson, D. J. & Gwyer Findlay, E. L., 24 Feb 2021, In: Nature Communications.
Research output: Contribution to journal › Article › peer-review

Open Access
File
Exposure to the antimicrobial peptide LL-37 produces dendritic cells optimized for immunotherapy
Findlay, E. G., Currie, A. J., Zhang, A., Ovciarikova, J., Young, L., Stevens, H., McHugh, B. J., Canel, M., Gray, M., Milling, S. W. F., Campbell, J. D. M., Savill, J., Serrels, A. & Davidson, D. J., 1 May 2019, (E-pub ahead of print) In: OncoImmunology. p. 1-17
Research output: Contribution to journal › Article › peer-review

Open Access
File